Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 251

1.

Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: results at 5 years from the French prospective registry ITP-ritux.

Deshayes S, Khellaf M, Zarour A, Layese R, Fain O, Terriou L, Viallard JF, Cheze S, Graveleau J, Slama B, Audia S, Cliquennois M, Ebbo M, Le Guenno G, Salles G, Bonmati C, Teillet F, Galicier L, Lambotte O, Hot A, Lefrère F, Mahévas M, Canoui-Poitrine F, Michel M, Godeau B.

Am J Hematol. 2019 Sep 5. doi: 10.1002/ajh.25632. [Epub ahead of print]

PMID:
31489694
2.

Second-line and beyond: treatment options for primary persistent and chronic immune thrombocytopenia.

Deshayes S, Godeau B.

Platelets. 2019 Jul 5:1-9. doi: 10.1080/09537104.2019.1636018. [Epub ahead of print]

PMID:
31272259
3.

Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia.

González-Porras JR, Godeau B, Carpenedo M.

Ther Adv Hematol. 2019 May 9;10:2040620719837906. doi: 10.1177/2040620719837906. eCollection 2019. Review.

4.

Bortezomib and dexamethasone, an original approach for treating multi-refractory warm autoimmune haemolytic anaemia.

Fadlallah J, Michel M, Crickx E, Limal N, Costedoat N, Malphettes M, Fieschi C, Galicier L, Oksenhendler E, Godeau B, Audia S, Mahévas M.

Br J Haematol. 2019 Jun 2. doi: 10.1111/bjh.16009. [Epub ahead of print]

PMID:
31155716
5.

[Hemophagocytic lymphohistiocytosis with granulomatosis and diffuse T-cell infiltration associated with disseminated Nocardiosis and pulmonary infection due to Streptomyces spp].

Canouï E, Ingen-Housz-Oro S, Ortonne N, Lebeaux D, Rodriguez-Nava V, Godeau B, Mahévas M.

Rev Med Interne. 2019 Jul;40(7):457-461. doi: 10.1016/j.revmed.2019.04.013. Epub 2019 May 15. French.

PMID:
31103241
6.

Thrombopoietin receptor agonists: ten years later.

Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB.

Haematologica. 2019 Jun;104(6):1112-1123. doi: 10.3324/haematol.2018.212845. Epub 2019 May 9. Review.

7.

Update in Neurocritical Care: a summary of the 2018 Paris international conference of the French Society of Intensive Care.

Oddo M, Bracard S, Cariou A, Chanques G, Citerio G, Clerckx B, Godeau B, Godier A, Horn J, Jaber S, Jung B, Kuteifan K, Leone M, Mailles A, Mazighi M, Mégarbane B, Outin H, Puybasset L, Sharshar T, Sandroni C, Sonneville R, Weiss N, Taccone FS.

Ann Intensive Care. 2019 Apr 16;9(1):47. doi: 10.1186/s13613-019-0523-x. Review.

8.

Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphoma.

Crickx E, Poullot E, Moulis G, Goulabchand R, Fieschi C, Galicier L, Meignin V, Coppo P, Delarue R, Casasnovas O, Roos-Weil D, de Leval L, Parrens M, Michel M, Dupuis J, Le Bras F, Fataccioli V, Martin-Garcia N, Godeau B, Haïoun C, Gaulard P, Mahévas M.

Eur J Haematol. 2019 Jul;103(1):35-42. doi: 10.1111/ejh.13239. Epub 2019 May 30.

PMID:
30985955
9.

Autologous111 Indium-oxinate-labelled platelet sequestration study in patients with immune thrombocytopenia treated by thrombopoietin receptor-agonists.

Mahevas M, Van Eeckhoudt S, Moulis G, Limal N, Languille L, Bierling P, Dossier A, Duriez F, Galicier L, Morin AS, Tamburini J, Chaoui D, Bouscary D, Jijakli AAL, Khellaf M, Vaida I, Michel M, Vercellino L, Jaddi H, Yollant A, Dosquet C, Godeau B, Chomienne C.

Br J Haematol. 2019 Aug;186(3):e44-e47. doi: 10.1111/bjh.15890. Epub 2019 Apr 4. No abstract available.

PMID:
30950041
10.

Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patients.

Durel CA, Hot A, Trefond L, Aumaitre O, Pugnet G, Samson M, Abad S, Belot A, Blanchard-Delaunay C, Cohen P, Cohen-Aubard F, Cottin V, Crestani B, Moreuil C, Durupt S, Garzaro M, Girszyn N, Godeau B, Hachulla E, Jamilloux Y, Jego P, Killian M, Lazaro E, Le Gallou T, Liozon E, Martin T, Papo T, Perlat A, Pillet P, Guillevin L, Terrier B.

Rheumatology (Oxford). 2019 Sep 1;58(9):1565-1573. doi: 10.1093/rheumatology/kez071.

PMID:
30887055
11.

Characteristics, risk factors and management of venous thromboembolism in immune thrombocytopenia: a retrospective multicentre study.

Le Guenno G, Guieze R, Audia S, Khellaf M, Michel M, Bonnotte B, Ruivard M, Godeau B.

Intern Med J. 2019 Sep;49(9):1154-1162. doi: 10.1111/imj.14269.

PMID:
30816621
12.

Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients.

Picard V, Guitton C, Thuret I, Rose C, Bendelac L, Ghazal K, Aguilar-Martinez P, Badens C, Barro C, Bénéteau C, Berger C, Cathébras P, Deconinck E, Delaunay J, Durand JM, Firah N, Galactéros F, Godeau B, Jaïs X, de Jaureguiberry JP, Le Stradic C, Lifermann F, Maffre R, Morin G, Perrin J, Proulle V, Ruivard M, Toutain F, Lahary A, Garçon L.

Haematologica. 2019 Aug;104(8):1554-1564. doi: 10.3324/haematol.2018.205328. Epub 2019 Jan 17.

13.

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study.

Delanoy N, Michot JM, Comont T, Kramkimel N, Lazarovici J, Dupont R, Champiat S, Chahine C, Robert C, Herbaux C, Besse B, Guillemin A, Mateus C, Pautier P, Saïag P, Madonna E, Maerevoet M, Bout JC, Leduc C, Biscay P, Quere G, Nardin C, Ebbo M, Albigès L, Marret G, Levrat V, Dujon C, Vargaftig J, Laghouati S, Croisille L, Voisin AL, Godeau B, Massard C, Ribrag V, Marabelle A, Michel M, Lambotte O.

Lancet Haematol. 2019 Jan;6(1):e48-e57. doi: 10.1016/S2352-3026(18)30175-3. Epub 2018 Dec 4.

PMID:
30528137
14.

Severe, non specific symptoms in non-typhoidal Salmonella infections in adult patients with sickle cell disease: a retrospective multicentre study.

Guery R, Habibi A, Arlet JB, Lionnet F, de Lastours V, Decousser JW, Mainardi JL, Razazi K, Baranes L, Bartolucci P, Godeau B, Galacteros F, Michel M, Mahevas M.

Infect Dis (Lond). 2018 Nov - Dec;50(11-12):822-830. doi: 10.1080/23744235.2018.1500706. Epub 2018 Oct 14.

PMID:
30317897
15.

Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults.

Piel-Julian ML, Mahévas M, Germain J, Languille L, Comont T, Lapeyre-Mestre M, Payrastre B, Beyne-Rauzy O, Michel M, Godeau B, Adoue D, Moulis G; CARMEN investigators group.

J Thromb Haemost. 2018 Sep;16(9):1830-1842. doi: 10.1111/jth.14227. Epub 2018 Aug 12.

PMID:
29978544
16.

Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists.

Guitton Z, Terriou L, Lega JC, Nove-Josserand R, Hie M, Amoura Z, Bussel JB, Hamidou M, Rosenthal E, Lioger B, Chauveau D, Chaminade A, Magy-Bertrand N, Michel M, Audia S, Godeau B, Mahevas M.

Rheumatology (Oxford). 2018 Aug 1;57(8):1432-1438. doi: 10.1093/rheumatology/key119.

PMID:
29757439
17.

Systematic detection of portal or splenic vein thrombosis after splenectomy for immune cytopenia.

Morbieu C, Brunetti F, Baranès L, Languille L, Limal N, Loustau V, Bierling P, Michel M, Godeau B, Mahévas M.

Am J Hematol. 2018 Jul;93(7):E170-E172. doi: 10.1002/ajh.25120. No abstract available.

18.

Pretreatment with standard-dose intravenous methylprednisolone does not improve outcomes in newly diagnosed immune thrombocytopenia (ITP).

Essilini A, Comont T, Germain J, Brun N, Dingremont C, Castel B, Arista S, Madaule S, Sailler L, Lapeyre-Mestre M, Beyne-Rauzy O, Godeau B, Adoue D, Moulis G; CARMEN investigators group.

Eur J Haematol. 2018 May;100(5):412-418. doi: 10.1111/ejh.13032. Epub 2018 Mar 12.

PMID:
29360249
19.

Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.

Serris A, Amoura Z, Canouï-Poitrine F, Terrier B, Hachulla E, Costedoat-Chalumeau N, Papo T, Lambotte O, Saadoun D, Hié M, Blanche P, Lioger B, Gottenberg JE, Godeau B, Michel M.

Am J Hematol. 2018 Mar;93(3):424-429. doi: 10.1002/ajh.24999. Epub 2018 Jan 25.

20.

Clinical severity in adult warm autoimmune hemolytic anemia and its relationship to antibody specificity.

Chadebech P, Loustau V, Janvier D, Languille L, Ripa J, Tamagne M, Bierling P, Djoudi R, Godeau B, Michel M, Pirenne F, Mahévas M.

Haematologica. 2018 Jan;103(1):e35-e38. doi: 10.3324/haematol.2017.175976. Epub 2017 Oct 12. No abstract available.

21.

Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.

Narbey D, Habibi A, Chadebech P, Mekontso-Dessap A, Khellaf M, Lelièvre JD, Godeau B, Michel M, Galactéros F, Djoudi R, Bartolucci P, Pirenne F.

Am J Hematol. 2017 Dec;92(12):1340-1348. doi: 10.1002/ajh.24908. Epub 2017 Oct 31.

22.

Erratum: Efficacy and safety of ClairYg®, a ready-to-use intravenous immunoglobulin, in adult patients with primary immune thrombocytopenia.

Slama B, Fain O, Maisonneuve H, Jourdan E, Viallard JF, Ouaja R, Alfa-Cissé O, Godeau B; Study Investigators.

Am J Blood Res. 2017 Jun 15;7(3):29. eCollection 2017.

23.

Pathogenesis of immune thrombocytopenia.

Audia S, Mahévas M, Samson M, Godeau B, Bonnotte B.

Autoimmun Rev. 2017 Jun;16(6):620-632. doi: 10.1016/j.autrev.2017.04.012. Epub 2017 Apr 17. Review.

PMID:
28428120
24.

Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.

Moulis G, Germain J, Comont T, Brun N, Dingremont C, Castel B, Arista S, Sailler L, Lapeyre-Mestre M, Beyne-Rauzy O, Godeau B, Adoue D; CARMEN Investigators Group.

Am J Hematol. 2017 Jun;92(6):493-500. doi: 10.1002/ajh.24702. Epub 2017 Mar 20.

25.

Efficacy and safety of ClairYg®, a ready-to-use intravenous immunoglobulin, in adult patients with primary immune thrombocytopenia.

Slama B, Fain O, Maisonneuve H, Jourdan E, Viallard JF, Ouaja R, Alfa-Cissé O, Godeau B; Study Investigators.

Am J Blood Res. 2017 Jan 15;7(1):1-9. eCollection 2017. Erratum in: Am J Blood Res. 2017 Jun 15;7(3):29.

26.

Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance.

Grimaldi-Bensouda L, Rossignol M, Koné-Paut I, Krivitzky A, Lebrun-Frenay C, Clet J, Brassat D, Papeix C, Nicolino M, Benhamou PY, Fain O, Costedoat-Chalumeau N, Courcoux MF, Viallard JF, Godeau B, Papo T, Vermersch P, Bourgault-Villada I, Breart G, Abenhaim L; PGRx-AD Study Group.

J Autoimmun. 2017 May;79:84-90. doi: 10.1016/j.jaut.2017.01.005. Epub 2017 Feb 9.

27.

Long-term complications of splenectomy in adult immune thrombocytopenia.

Thai LH, Mahévas M, Roudot-Thoraval F, Limal N, Languille L, Dumas G, Khellaf M, Bierling P, Michel M, Godeau B.

Medicine (Baltimore). 2016 Nov;95(48):e5098.

28.

Treatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetil.

Bitoun S, Bouvry D, Borie R, Mahevas M, Sacre K, Haroche J, Psimaras D, Pottier C, Mathian A, Hie M, Boutin DL, Papo T, Godeau B, Valeyre D, Nunes H, Amoura Z, Cohen Aubart F.

Neurology. 2016 Dec 13;87(24):2517-2521. Epub 2016 Nov 16.

PMID:
27856779
29.

[Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study].

Weber E, Moulis G, Mahévas M, Guy C, Lioger B, Durieu I, Hunault M, Ramanantsoa M, Royer B, Default A, Pérault-Pochat MC, Moachon L, Bernard N, Bardy G, Jonville-Bera AP, Geniaux H, Godeau B, Cathébras P.

Rev Med Interne. 2017 Mar;38(3):167-175. doi: 10.1016/j.revmed.2016.09.016. Epub 2016 Oct 25. French.

PMID:
27793553
30.

Seasonal variations of incident primary immune thrombocytopenia in adults: An ecological study.

Moulis G, Guénin S, Limal N, Michel M, Bierling P, Godeau B, Mahévas M.

Eur J Intern Med. 2017 Jan;37:e26-e28. doi: 10.1016/j.ejim.2016.09.025. Epub 2016 Oct 7. No abstract available.

PMID:
27727074
31.

A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study).

Michel M, Terriou L, Roudot-Thoraval F, Hamidou M, Ebbo M, Le Guenno G, Galicier L, Audia S, Royer B, Morin AS, Marie Michot J, Jaccard A, Frenzel L, Khellaf M, Godeau B.

Am J Hematol. 2017 Jan;92(1):23-27. doi: 10.1002/ajh.24570. Epub 2016 Nov 10.

32.

Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.

Deux JF, Audard V, Brugières P, Habibi A, Manea EM, Guillaud-Danis C, Godeau B, Galactéros F, Stehlé T, Lang P, Grimbert P, Audureau E, Rahmouni A, Bartolucci P.

Am J Kidney Dis. 2017 Jan;69(1):51-59. doi: 10.1053/j.ajkd.2016.07.027. Epub 2016 Sep 20.

PMID:
27663041
33.

High-dose dexamethasone or oral prednisone for immune thrombocytopenia?

Godeau B.

Lancet Haematol. 2016 Oct;3(10):e453-e454. doi: 10.1016/S2352-3026(16)30124-7. Epub 2016 Sep 16. No abstract available.

PMID:
27658979
34.

Risk factors associated with intracranial hemorrhage in adults with immune thrombocytopenia: A study of 27 cases.

Melboucy-Belkhir S, Khellaf M, Augier A, Boubaya M, Levy V, Le Guenno G, Terriou L, Lioger B, Ebbo M, Morin AS, Chauveheid MP, Michel M, Belkhir F, About F, Rose C, Moulis G, Mekinian A, Stirnemann J, Papo T, Cheze S, Rosenthal E, Viallard JF, Schleinitz N, Galicier L, Adoue D, Lambotte O, Hamidou M, Godeau B, Fain O.

Am J Hematol. 2016 Dec;91(12):E499-E501. doi: 10.1002/ajh.24529. Epub 2016 Aug 22. No abstract available.

35.

Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.

Bartolucci P, Habibi A, Khellaf M, Roudot-Thoraval F, Melica G, Lascaux AS, Moutereau S, Loric S, Wagner-Ballon O, Berkenou J, Santin A, Michel M, Renaud B, Lévy Y, Galactéros F, Godeau B.

EBioMedicine. 2016 Aug;10:305-11. doi: 10.1016/j.ebiom.2016.06.038. Epub 2016 Jun 29.

36.

Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia.

Mahévas M, Gerfaud-Valentin M, Moulis G, Terriou L, Audia S, Guenin S, Le Guenno G, Salles G, Lambotte O, Limal N, Viallard JF, Cheze S, Tomowiak C, Royer B, Neel A, Debouverie O, Hot A, Durieu I, Perlat A, Cliquennois M, Deteix C, Michel M, Godeau B.

Blood. 2016 Sep 22;128(12):1625-30. doi: 10.1182/blood-2016-03-704734. Epub 2016 Jun 27.

37.

Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes.

Habibi A, Mekontso-Dessap A, Guillaud C, Michel M, Razazi K, Khellaf M, Chami B, Bachir D, Rieux C, Melica G, Godeau B, Galacteros F, Bartolucci P, Pirenne F.

Am J Hematol. 2016 Oct;91(10):989-94. doi: 10.1002/ajh.24460. Epub 2016 Jul 14.

38.

Immunomodulation and immune thrombocytopenia: some unmet needs, questions, and outlook.

Godeau B.

Semin Hematol. 2016 Apr;53 Suppl 1:S39-42. doi: 10.1053/j.seminhematol.2016.04.012. Epub 2016 Apr 7.

PMID:
27312163
39.

No impact of PTPN22, PTPRJ and ACP1 genes polymorphisms on the risk of immune thrombocytopenia in French adult patients.

Lioger B, Rollin J, Vayne C, Perret-Gallix K, Pouplard C, Godeau B, Michel M, Gruel Y.

Thromb Res. 2016 Aug;144:76-8. doi: 10.1016/j.thromres.2016.04.013. Epub 2016 Apr 25. No abstract available.

PMID:
27309885
40.

Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome.

Grimaldi-Bensouda L, Nordon C, Michel M, Viallard JF, Adoue D, Magy-Bertrand N, Durand JM, Quittet P, Fain O, Bonnotte B, Morin AS, Morel N, Costedoat-Chalumeau N, Pan-Petesch B, Khellaf M, Perlat A, Sacre K, Lefrere F, Abenhaim L, Godeau B; Group for the PGRx-ITP Study.

Haematologica. 2016 Sep;101(9):1039-45. doi: 10.3324/haematol.2016.146373. Epub 2016 May 26.

41.

How we manage immune thrombocytopenia in the elderly.

Mahévas M, Michel M, Godeau B.

Br J Haematol. 2016 Jun;173(6):844-56. doi: 10.1111/bjh.14067. Epub 2016 Apr 7. Review.

PMID:
27062054
42.

Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients.

Jachiet M, Samson M, Cottin V, Kahn JE, Le Guenno G, Bonniaud P, Devilliers H, Bouillet L, Gondouin A, Makhlouf F, Meaux-Ruault N, Gil H, Bienvenu B, Coste A, Groh M, Giraud V, Dominique S, Godeau B, Puéchal X, Khouatra C, Ruivard M, Le Jeunne C, Mouthon L, Guillevin L, Terrier B; French Vasculitis Study Group.

Arthritis Rheumatol. 2016 Sep;68(9):2274-82. doi: 10.1002/art.39663.

43.

Thymic Epithelial Tumor-Associated Cytopenia: A 10-Year Observational Study in France.

Rivoisy C, Besse B, Girard N, Lioger B, Viallard JF, Lega JC, Rullier P, Perlat A, Lerouge D, Clement-Duchene C, Ebbo M, Bosseray A, Godeau B, Lambotte O.

J Thorac Oncol. 2016 Mar;11(3):391-9. doi: 10.1016/j.jtho.2015.11.012. Epub 2016 Jan 4.

44.

Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysis.

Moulis G, Audemard-Verger A, Arnaud L, Luxembourger C, Montastruc F, Gaman AM, Svenungsson E, Ruggeri M, Mahévas M, Gerfaud-Valentin M, Brainsky A, Michel M, Godeau B, Lapeyre-Mestre M, Sailler L.

Autoimmun Rev. 2016 Mar;15(3):203-9. doi: 10.1016/j.autrev.2015.11.001. Epub 2015 Dec 19. Review.

PMID:
26708169
45.

NK cell compartment in the peripheral blood and spleen in adult patients with primary immune thrombocytopenia.

Ebbo M, Audonnet S, Grados A, Benarous L, Mahevas M, Godeau B, Viallard JF, Piperoglou C, Cognet C, Farnarier C, Harlé JR, Schleinitz N, Vély F.

Clin Immunol. 2017 Apr;177:18-28. doi: 10.1016/j.clim.2015.11.005. Epub 2015 Nov 18.

PMID:
26598010
46.

Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.

Bartolucci P, Habibi A, Stehlé T, Di Liberto G, Rakotoson MG, Gellen-Dautremer J, Loric S, Moutereau S, Sahali D, Wagner-Ballon O, Remy P, Lang P, Grimbert P, Audureau E, Godeau B, Galacteros F, Audard V.

J Am Soc Nephrol. 2016 Jun;27(6):1847-53. doi: 10.1681/ASN.2014111126. Epub 2015 Nov 19.

47.

Kikuchi Disease-Like Inflammatory Pattern in Cutaneous Inflammatory Infiltrates Without Lymph Node Involvement: A New Clue for the Diagnosis of Lupus?

Thai LH, Ingen-Housz-Oro S, Godeau B, Rethers L, Wolkenstein P, Limal N, Papillon V, Kapfer J, Chosidow O, Ortonne N.

Medicine (Baltimore). 2015 Nov;94(46):e2065. doi: 10.1097/MD.0000000000002065.

48.

Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.

Newland A, Godeau B, Priego V, Viallard JF, López Fernández MF, Orejudos A, Eisen M.

Br J Haematol. 2016 Jan;172(2):262-73. doi: 10.1111/bjh.13827. Epub 2015 Nov 5.

PMID:
26537623
49.

Haematological determinants of cardiac involvement in adults with sickle cell disease.

Damy T, Bodez D, Habibi A, Guellich A, Rappeneau S, Inamo J, Guendouz S, Gellen-Dautremer J, Pissard S, Loric S, Wagner-Ballon O, Godeau B, Adnot S, Dubois-Randé JL, Hittinger L, Galactéros F, Bartolucci P.

Eur Heart J. 2016 Apr 7;37(14):1158-1167. doi: 10.1093/eurheartj/ehv555. Epub 2015 Oct 29.

PMID:
26516176
50.

Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two Patients.

Crickx E, Machelart I, Lazaro E, Kahn JE, Cohen-Aubart F, Martin T, Mania A, Hatron PY, Hayem G, Blanchard-Delaunay C, de Moreuil C, Le Guenno G, Vandergheynst F, Maurier F, Crestani B, Dhote R, Silva NM, Ollivier Y, Mehdaoui A, Godeau B, Mariette X, Cadranel J, Cohen P, Puéchal X, Le Jeunne C, Mouthon L, Guillevin L, Terrier B; French Vasculitis Study Group.

Arthritis Rheumatol. 2016 Mar;68(3):702-12. doi: 10.1002/art.39472.

Supplemental Content

Loading ...
Support Center